Incidence of Hepatitis A in Argentina after vaccination

M N Vacchino1

  • 1ANLIS_National Institute of Epidemiology Dr. Juan H. Jara, Mar del Plata, Argentina. vacchinomarta@yahoo.com.ar

Insights

Argentina

Area of Science:

  • Epidemiology
  • Immunization Programs
  • Public Health

Background:

  • Hepatitis A incidence in Argentina was high (70.5-173.8 per 100,000) between 1995-2004.
  • A universal, single-dose hepatitis A vaccination program for 12-month-old children began in June 2005.

Purpose of the Study:

  • To evaluate the impact of universal hepatitis A vaccination in Argentina.
  • To assess changes in disease incidence following the immunization program.

Main Methods:

  • Longitudinal analysis of hepatitis A data from Argentina's National Notifiable Diseases Surveillance System (SINAVE).
  • Comparison of 2007 incidence rates with the 1998-2002 pre-vaccination baseline period.
  • Analysis by age group and geographical region.

Main Results:

  • Overall hepatitis A incidence decreased by 88.0% in 2007 (10.2 per 100,000) compared to the baseline (P < 0.001).
  • Significant reductions observed across all age groups, including 83.1% in 1-year-olds.
  • Substantial declines noted in all Argentinian regions.

Conclusions:

  • Universal, single-dose hepatitis A vaccination in infants significantly reduced disease rates in Argentina.
  • Sustained monitoring is crucial to ensure continued vaccination coverage and maintain low incidence.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...